ANEST IWATA Corporation Logo

ANEST IWATA Corporation

6381.T

(3.0)
Stock Price

1.484,00 JPY

7.08% ROA

10.45% ROE

12.05x PER

Market Cap.

55.427.765.839,00 JPY

2.42% DER

3.5% Yield

8.57% NPM

ANEST IWATA Corporation Stock Analysis

ANEST IWATA Corporation Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

ANEST IWATA Corporation Fundamental Stock Analysis
# Analysis Rating
1 DER

The stock has a low debt to equity ratio (3%), which means it has a small amount of debt compared to the ownership it holds

2 Assets Growth

Over the past five years, this company's revenue has consistently increased, demonstrating a robust financial performance that makes it an appealing opportunity.

3 Dividend Growth

The company has demonstrated exceptional dividend growth over the past five years, consistently increasing payouts to shareholders year after year.

4 ROE

ROE in an average range (11.32%) suggests satisfactory profitability and decent utilization of shareholders' equity.

5 ROA

The stock's ROA (8.27%) shows that it's doing a pretty good job at making money from its assets, making it a solid choice to invest and earn steady profits.

6 PBV

The stock's PBV ratio (1.23x) reflects a fair valuation, making it an attractive option for investors seeking balanced opportunities.

7 Graham Number

The Graham number analysis indicates that this company's stock price is likely undervalued, raising prospects for a favorable investment opportunity.

8 Dividend

The company's track record of consistently paying dividends in the last three years highlights its dedication to providing investors with regular income.

9 Buffet Intrinsic Value

The company's stock seems undervalued (13.294) by Warren Buffett's formula, indicating a promising investment opportunity as its intrinsic value exceeds the market price.

10 Revenue Growth

Company has experienced no growth in revenue over the past three years, suggesting limited profitability and making it a less desirable investment opportunity.

11 Net Profit Growth

Over the past five years, this company's net profit has failed to exhibit any growth, indicating a stagnant financial performance and making it a less favorable choice for potential investors.

ANEST IWATA Corporation Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

ANEST IWATA Corporation Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Hold
2 MACD Buy
3 RSI Hold
4 Stoch RSI Sell

ANEST IWATA Corporation Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

ANEST IWATA Corporation Revenue
Year Revenue Growth
2007 28.096.344.000
2008 22.435.189.000 -25.23%
2009 17.886.116.000 -25.43%
2010 20.171.000.000 11.33%
2011 21.212.262.000 4.91%
2012 22.540.832.000 5.89%
2013 25.457.476.000 11.46%
2014 28.376.586.000 10.29%
2015 29.524.831.000 3.89%
2016 29.548.526.000 0.08%
2017 32.817.481.000 9.96%
2018 38.807.259.000 15.43%
2019 39.091.312.000 0.73%
2020 35.588.516.000 -9.84%
2021 42.337.011.000 15.94%
2022 48.515.155.000 12.73%
2023 54.892.000.000 11.62%
2023 53.425.000.000 -2.75%
2024 49.936.000.000 -6.99%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

ANEST IWATA Corporation Research and Development Expenses
Year Research and Development Expenses Growth
2007 0
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 897.000.000 100%
2013 983.000.000 8.75%
2014 854.000.000 -15.11%
2015 1.017.000.000 16.03%
2016 1.111.978.000 8.54%
2017 521.424.999 -113.26%
2018 1.153.000.000 54.78%
2019 1.084.000.000 -6.37%
2020 1.045.000.000 -3.73%
2021 1.047.000.000 0.19%
2022 1.355.000.000 22.73%
2023 0 0%
2023 853.000.000 100%
2024 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

ANEST IWATA Corporation General and Administrative Expenses
Year General and Administrative Expenses Growth
2007 3.732.164.000
2008 3.600.274.000 -3.66%
2009 3.116.354.000 -15.53%
2010 3.277.658.000 4.92%
2011 3.390.576.000 3.33%
2012 3.663.040.000 7.44%
2013 4.092.474.000 10.49%
2014 4.401.289.000 7.02%
2015 4.518.025.000 2.58%
2016 4.562.977.000 0.99%
2017 797.510.000 -472.15%
2018 899.922.000 11.38%
2019 871.815.000 -3.22%
2020 784.089.000 -11.19%
2021 2.277.139.000 65.57%
2022 2.569.466.000 11.38%
2023 0 0%
2023 3.084.000.000 100%
2024 0 0%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

ANEST IWATA Corporation EBITDA
Year EBITDA Growth
2007 6.374.703.000
2008 4.375.330.000 -45.7%
2009 3.247.997.000 -34.71%
2010 4.635.718.000 29.94%
2011 4.725.571.000 1.9%
2012 5.277.655.000 10.46%
2013 6.769.336.000 22.04%
2014 7.896.686.000 14.28%
2015 8.565.014.000 7.8%
2016 8.539.550.000 -0.3%
2017 5.786.466.000 -47.58%
2018 6.668.008.000 13.22%
2019 6.262.237.000 -6.48%
2020 5.948.786.000 -5.27%
2021 7.394.903.000 19.56%
2022 9.178.175.000 19.43%
2023 7.860.000.000 -16.77%
2023 8.427.000.000 6.73%
2024 6.416.000.000 -31.34%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

ANEST IWATA Corporation Gross Profit
Year Gross Profit Growth
2007 10.719.255.000
2008 8.800.633.000 -21.8%
2009 6.902.655.000 -27.5%
2010 8.456.958.000 18.38%
2011 8.635.517.000 2.07%
2012 9.258.578.000 6.73%
2013 11.153.492.000 16.99%
2014 12.161.650.000 8.29%
2015 13.038.323.000 6.72%
2016 12.990.711.000 -0.37%
2017 14.433.048.000 9.99%
2018 16.777.108.000 13.97%
2019 16.586.170.000 -1.15%
2020 14.926.323.000 -11.12%
2021 18.227.775.000 18.11%
2022 21.337.049.000 14.57%
2023 24.268.000.000 12.08%
2023 24.475.000.000 0.85%
2024 22.824.000.000 -7.23%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

ANEST IWATA Corporation Net Profit
Year Net Profit Growth
2007 2.313.453.000
2008 1.376.478.000 -68.07%
2009 711.524.000 -93.45%
2010 1.379.265.000 48.41%
2011 1.322.181.000 -4.32%
2012 1.780.018.000 25.72%
2013 2.181.900.000 18.42%
2014 2.303.340.000 5.27%
2015 2.593.847.000 11.2%
2016 3.400.898.000 23.73%
2017 2.809.919.000 -21.03%
2018 2.947.727.000 4.68%
2019 2.717.840.000 -8.46%
2020 2.623.282.000 -3.6%
2021 3.541.395.000 25.93%
2022 4.381.000.000 19.16%
2023 4.988.000.000 12.17%
2023 4.931.000.000 -1.16%
2024 4.208.000.000 -17.18%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

ANEST IWATA Corporation Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2007 50
2008 30 -68.97%
2009 15 -93.33%
2010 31 50%
2011 30 0%
2012 42 26.83%
2013 52 19.61%
2014 53 1.92%
2015 62 16.13%
2016 81 23.46%
2017 67 -20.9%
2018 71 4.29%
2019 65 -7.69%
2020 63 -3.17%
2021 86 26.74%
2022 108 20.37%
2023 0 0%
2023 122 100%
2024 106 -15.09%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

ANEST IWATA Corporation Free Cashflow
Year Free Cashflow Growth
2007 1.570.777.000
2008 1.172.502.000 -33.97%
2009 1.386.232.000 15.42%
2010 2.149.485.000 35.51%
2011 387.639.000 -454.51%
2012 1.516.858.000 74.44%
2013 869.855.000 -74.38%
2014 1.220.356.000 28.72%
2015 2.688.687.000 54.61%
2016 2.366.710.000 -13.6%
2017 2.163.203.000 -9.41%
2018 3.227.608.000 32.98%
2019 3.162.474.000 -2.06%
2020 3.836.140.000 17.56%
2021 2.454.885.000 -56.27%
2022 2.156.183.000 -13.85%
2023 0 0%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

ANEST IWATA Corporation Operating Cashflow
Year Operating Cashflow Growth
2007 2.685.331.000
2008 1.670.453.000 -60.75%
2009 1.778.636.000 6.08%
2010 2.620.514.000 32.13%
2011 879.188.000 -198.06%
2012 2.727.975.000 67.77%
2013 2.652.365.000 -2.85%
2014 2.397.894.000 -10.61%
2015 3.749.940.000 36.06%
2016 3.397.211.000 -10.38%
2017 4.079.713.000 16.73%
2018 4.848.026.000 15.85%
2019 4.141.396.000 -17.06%
2020 4.602.183.000 10.01%
2021 3.889.943.000 -18.31%
2022 4.329.170.000 10.15%
2023 0 0%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

ANEST IWATA Corporation Capital Expenditure
Year Capital Expenditure Growth
2007 1.114.554.000
2008 497.951.000 -123.83%
2009 392.404.000 -26.9%
2010 471.029.000 16.69%
2011 491.549.000 4.17%
2012 1.211.117.000 59.41%
2013 1.782.510.000 32.06%
2014 1.177.538.000 -51.38%
2015 1.061.253.000 -10.96%
2016 1.030.501.000 -2.98%
2017 1.916.510.000 46.23%
2018 1.620.418.000 -18.27%
2019 978.922.000 -65.53%
2020 766.043.000 -27.79%
2021 1.435.058.000 46.62%
2022 2.172.987.000 33.96%
2023 0 0%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

ANEST IWATA Corporation Equity
Year Equity Growth
2007 16.942.142.000
2008 16.821.492.000 -0.72%
2009 17.440.804.000 3.55%
2010 17.367.534.000 -0.42%
2011 17.852.623.000 2.72%
2012 19.677.692.000 9.27%
2013 21.783.291.000 9.67%
2014 24.689.528.000 11.77%
2015 25.518.735.000 3.25%
2016 28.605.483.000 10.79%
2017 32.777.738.000 12.73%
2018 33.502.896.000 2.16%
2019 34.570.470.000 3.09%
2020 36.133.901.000 4.33%
2021 40.210.004.000 10.14%
2022 45.255.451.000 11.15%
2023 50.074.000.000 9.62%
2023 49.061.000.000 -2.06%
2024 50.974.000.000 3.75%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

ANEST IWATA Corporation Assets
Year Assets Growth
2007 26.911.964.000
2008 23.482.733.000 -14.6%
2009 24.140.502.000 2.72%
2010 24.468.966.000 1.34%
2011 24.716.142.000 1%
2012 27.565.715.000 10.34%
2013 30.856.619.000 10.67%
2014 33.766.133.000 8.62%
2015 34.678.415.000 2.63%
2016 38.895.360.000 10.84%
2017 47.307.844.000 17.78%
2018 47.557.798.000 0.53%
2019 48.102.044.000 1.13%
2020 49.458.678.000 2.74%
2021 55.818.537.000 11.39%
2022 60.136.510.000 7.18%
2023 66.144.000.000 9.08%
2023 64.080.000.000 -3.22%
2024 65.815.000.000 2.64%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

ANEST IWATA Corporation Liabilities
Year Liabilities Growth
2007 9.969.822.000
2008 6.661.241.000 -49.67%
2009 6.699.698.000 0.57%
2010 7.101.432.000 5.66%
2011 6.863.519.000 -3.47%
2012 7.888.023.000 12.99%
2013 9.073.328.000 13.06%
2014 9.076.605.000 0.04%
2015 9.159.680.000 0.91%
2016 10.289.877.000 10.98%
2017 14.530.106.000 29.18%
2018 14.054.902.000 -3.38%
2019 13.531.574.000 -3.87%
2020 13.324.777.000 -1.55%
2021 15.608.533.000 14.63%
2022 14.881.059.000 -4.89%
2023 16.066.000.000 7.38%
2023 15.019.000.000 -6.97%
2024 14.839.000.000 -1.21%

ANEST IWATA Corporation Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
1354.11
Net Income per Share
116.1
Price to Earning Ratio
12.05x
Price To Sales Ratio
1.03x
POCF Ratio
17.04
PFCF Ratio
17.01
Price to Book Ratio
1.24
EV to Sales
0.75
EV Over EBITDA
4.99
EV to Operating CashFlow
12.37
EV to FreeCashFlow
12.37
Earnings Yield
0.08
FreeCashFlow Yield
0.06
Market Cap
55,43 Bil.
Enterprise Value
40,29 Bil.
Graham Number
1719.3
Graham NetNet
364.07

Income Statement Metrics

Net Income per Share
116.1
Income Quality
0.66
ROE
0.1
Return On Assets
0.07
Return On Capital Employed
0.11
Net Income per EBT
0.6
EBT Per Ebit
1.3
Ebit per Revenue
0.11
Effective Tax Rate
0.27

Margins

Sales, General, & Administrative to Revenue
0.12
Research & Developement to Revenue
0.02
Stock Based Compensation to Revenue
0
Gross Profit Margin
0.46
Operating Profit Margin
0.11
Pretax Profit Margin
0.14
Net Profit Margin
0.09

Dividends

Dividend Yield
0.04
Dividend Yield %
3.5
Payout Ratio
0
Dividend Per Share
49

Operating Metrics

Operating Cashflow per Share
82.1
Free CashFlow per Share
82.1
Capex to Operating CashFlow
0
Capex to Revenue
0
Capex to Depreciation
0
Return on Invested Capital
0.09
Return on Tangible Assets
0.07
Days Sales Outstanding
61.82
Days Payables Outstanding
69.72
Days of Inventory on Hand
156.29
Receivables Turnover
5.9
Payables Turnover
5.24
Inventory Turnover
2.34
Capex per Share
0

Balance Sheet

Cash per Share
408,97
Book Value per Share
1.284,61
Tangible Book Value per Share
1266.49
Shareholders Equity per Share
1131.62
Interest Debt per Share
29.59
Debt to Equity
0.02
Debt to Assets
0.02
Net Debt to EBITDA
-1.88
Current Ratio
3.45
Tangible Asset Value
50,26 Bil.
Net Current Asset Value
25,21 Bil.
Invested Capital
43212000000
Working Capital
28,46 Bil.
Intangibles to Total Assets
0.01
Average Receivables
9,26 Bil.
Average Payables
5,62 Bil.
Average Inventory
12306000000
Debt to Market Cap
0.02

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

ANEST IWATA Corporation Dividends
Year Dividends Growth
2001 5
2002 4 0%
2003 4 0%
2004 6 33.33%
2006 2 -200%
2007 14 84.62%
2008 8 -85.71%
2010 10 30%
2011 10 -11.11%
2012 11 18.18%
2013 14 21.43%
2014 16 12.5%
2015 19 11.11%
2016 12 -50%
2017 21 42.86%
2018 21 0%
2019 23 8.7%
2020 24 4.17%
2021 25 4%
2022 28 10.71%
2023 44 36.36%
2024 49 10.2%
2025 0 0%

ANEST IWATA Corporation Profile

About ANEST IWATA Corporation

ANEST IWATA Corporation engages in the air energy and coating businesses in Japan and internationally. The company offers air compressors and nitrogen gas generators for various applications, such as factories, food production, hospitals, electric buses and new transportation systems, etc.; oil-free scroll vacuum pumps used in general industries, semiconductor manufacturing, food production, accelerators and synchrotron radiation facilities, etc.; steam power generators; spray guns, electrostatic coating machines, and paint supply equipment for industrial coating and automotive refinishing markets; and automatic painting devices, painting plants, painting robots, environmental devices, and painting booths. It also provides adhesive machinery, equipment, and systems; medical equipment; power supply units and power transmission devices. In addition, the company engages in the generation and sale of power derived from natural renewable energy. ANEST IWATA Corporation was founded in 1926 and is headquartered in Yokohama, Japan.

CEO
Mr. Shinichi Fukase
Employee
1.865
Address
3176, Shinyoshida-cho
Yokohama, 223-8501

ANEST IWATA Corporation Executives & BODs

ANEST IWATA Corporation Executives & BODs
# Name Age
1 Mr. Shinichi Fukase
President, Chief Executive Officer & Representative Director
70
2 Mr. Hajime Iwata
Chief Operating Officer of Business Administration Division & Director
70
3 Eisuke Miyoshi
Managing Executive Officer, Chief Operating Officer of Sales Division & Director
70
4 Satoru Iwata
President & Chief Operating Officer of ANEST IWATA Americas, Inc.
70
5 Mr. Kenichi Osawa
Senior Managing Executive Officer, Chief Operating Officer of Air Energy Division & Director
70
6 Hitoshi Iwata
Managing Executive Officer & Chief Operating Officer of Business Administration Division
70
7 Masanori Daimaru
Corporate Officer, GM of Development Engineering Department & Chief Operating Officer of Air Energy Division
70

ANEST IWATA Corporation Competitors